Yuxin Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yuxin Liu has a total of 186 co-authors. Here are the top co-authors by number of shared publications:
- Jing Zhou
Department of Chemistry Capital Normal University Beijing 100048 P. R. China
30 shared publications Qi Jia
Department of Chemistry & Beijing Key Lab. Opt. Mat. and Photon. Device Capital Normal University Beijing 100048 P. R. China
15 shared publicationsLiyi Ma
Department of Chemistry, Capital Normal University, Beijing 100048, People’s Republic of China
11 shared publications- Felix F. Loeffler
Department of Biomolecular Systems Max Planck Institute of Colloids and Interfaces 14476 Potsdam Germany
10 shared publications Zheng Wei
10 shared publicationsLidong Liu
Department of Chemistry, Capital Normal University, Beijing, 100048, PR China
9 shared publications
Latest Publications
- 12 November 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 394 (6825)
TMEM184 proteins are Ca 2+ uptake transporters in lysosomes
Lysosomal Ca 2+ release from acidic stores is critical for lysosomal function, yet the molecular identity of the Ca 2+ uptake conduit has remained elusive. We used a Ca 2+ -imaging–based genetic screen of the lysosomal membrane proteome to identify TMEM184 family proteins as lysosomal Ca 2+ transporters (LyCaTs) essential for Ca 2+ uptake and refilling. TMEM184 selectively transported Ca 2+ while excluding monovalent cations. Loss of TMEM184B/C depleted lysosomal Ca 2+ stores, diminished Ca 2+ release, and disrupted lysosomal exocytosis, biogenesis, and membrane repair, thus phenocopying the release channel transient receptor potential mucolipin 1 (TRPML1) deficiency. Moreover, a human TMEM184B mutation associated with a neurodevelopmental disorder compromised lysosomal Ca 2+ transport, and Tmem184b -deficient mice exhibited profound motor impairment. Thus, TMEM184 constitutes the long-sought Ca 2+ uptake and refilling mechanism that governs lysosomal signaling and homeostasis.
- 12 November 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 394 (6825)
TMEM184 proteins are Ca 2+ uptake transporters in lysosomes
Lysosomal Ca 2+ release from acidic stores is critical for lysosomal function, yet the molecular identity of the Ca 2+ uptake conduit has remained elusive. We used a Ca 2+ -imaging–based genetic screen of the lysosomal membrane proteome to identify TMEM184 family proteins as lysosomal Ca 2+ transporters (LyCaTs) essential for Ca 2+ uptake and refilling. TMEM184 selectively transported Ca 2+ while excluding monovalent cations. Loss of TMEM184B/C depleted lysosomal Ca 2+ stores, diminished Ca 2+ release, and disrupted lysosomal exocytosis, biogenesis, and membrane repair, thus phenocopying the release channel transient receptor potential mucolipin 1 (TRPML1) deficiency. Moreover, a human TMEM184B mutation associated with a neurodevelopmental disorder compromised lysosomal Ca 2+ transport, and Tmem184b -deficient mice exhibited profound motor impairment. Thus, TMEM184 constitutes the long-sought Ca 2+ uptake and refilling mechanism that governs lysosomal signaling and homeostasis.
- Open Access
- 14 October 2026
- Published by Wiley in Advanced Materials
- p. e75392
Synchronized Ablation of Multifocal Tumors Enabled by Multi‐Channel Lanthanide Nanocomposites
The multifocal nature of orthotopic breast tumors makes it difficult to treat due to individual tumor differences, requiring multiple therapeutic interventions. Here, a customized therapeutic strategy is presented for multiple tumors by using the same prescription based on a multi‐channel lanthanide nanocomposite and orthogonally controlled drug release. The upconversion luminescence of the nanocomposite at different wavelengths can monitor pH‐responsive mitoxantrone (MXT) release, reduced glutathione‐responsive near‐infrared (NIR) absorbance change, and eigen temperature, respectively, allowing modulation of photothermal treatment and temperature‐responsive paclitaxel release through customized whole‐body irradiation to achieve synchronized ablation of different individual tumors. Small animal experiments confirm multifocal breast tumors can be treated through this customized therapeutic strategy with both high efficiency and low overtherapy risk.
- 14 October 2026
- Published by Wiley in Advanced Materials
- p. e75392
Open AccessSynchronized Ablation of Multifocal Tumors Enabled by Multi‐Channel Lanthanide Nanocomposites
The multifocal nature of orthotopic breast tumors makes it difficult to treat due to individual tumor differences, requiring multiple therapeutic interventions. Here, a customized therapeutic strategy is presented for multiple tumors by using the same prescription based on a multi‐channel lanthanide nanocomposite and orthogonally controlled drug release. The upconversion luminescence of the nanocomposite at different wavelengths can monitor pH‐responsive mitoxantrone (MXT) release, reduced glutathione‐responsive near‐infrared (NIR) absorbance change, and eigen temperature, respectively, allowing modulation of photothermal treatment and temperature‐responsive paclitaxel release through customized whole‐body irradiation to achieve synchronized ablation of different individual tumors. Small animal experiments confirm multifocal breast tumors can be treated through this customized therapeutic strategy with both high efficiency and low overtherapy risk.
Sequentially Responsive Three‐Lobed Supramolecular Platform for Tumor Microenvironment Remodeling and Blood‐Brain Barrier Penetration
Glioblastoma (GBM) therapy is severely hindered by the inflammatory tumor microenvironment (TME) and insufficient penetration of biological barriers, which lead to poor therapeutic efficacy and severe side effects. Herein, we rationally designed and constructed a novel three‐lobed supramolecular delivery platform via π–π stacking and covalent cross‐linking, which enables enhanced responsiveness to the inflammatory TME and superior blood–brain barrier penetration for multi‐modal synergistic GBM therapy. Notably, this platform exhibits a sequential response to the inflammatory TME characterized by high ROS levels and acidic pH, thereby achieving on‐demand drug release, as well as efficient targeted accumulation across biological barriers. Furthermore, it exerts potent synergistic anti‐tumor effects through near infrared (NIR) photothermal ablation, chemotherapy, and JAG1/NOTCH1 signaling pathway inhibition, while maintaining excellent in vivo biocompatibility without obvious damage to normal tissues and organs. This multi‐module supramolecular assembly strategy provides a gradually progressive approach for precise therapy by anchoring the pathological characteristics, thereby advancing the revolutionary iteration of the GBM treatment system.
Sequentially Responsive Three‐Lobed Supramolecular Platform for Tumor Microenvironment Remodeling and Blood‐Brain Barrier Penetration
Glioblastoma (GBM) therapy is severely hindered by the inflammatory tumor microenvironment (TME) and insufficient penetration of biological barriers, which lead to poor therapeutic efficacy and severe side effects. Herein, we rationally designed and constructed a novel three‐lobed supramolecular delivery platform via π–π stacking and covalent cross‐linking, which enables enhanced responsiveness to the inflammatory TME and superior blood–brain barrier penetration for multi‐modal synergistic GBM therapy. Notably, this platform exhibits a sequential response to the inflammatory TME characterized by high ROS levels and acidic pH, thereby achieving on‐demand drug release, as well as efficient targeted accumulation across biological barriers. Furthermore, it exerts potent synergistic anti‐tumor effects through near infrared (NIR) photothermal ablation, chemotherapy, and JAG1/NOTCH1 signaling pathway inhibition, while maintaining excellent in vivo biocompatibility without obvious damage to normal tissues and organs. This multi‐module supramolecular assembly strategy provides a gradually progressive approach for precise therapy by anchoring the pathological characteristics, thereby advancing the revolutionary iteration of the GBM treatment system.
“Dual‐Hit” Photothermal and Immunogenicity Activation by Structurally Simple Carbon Dots‐Doped Hydrogel
Effective tumor treatment can only be achieved by combining short‐acting, localized therapy with long‐acting, systemic anti‐tumor immunogenicity. Herein, we report a “dual‐hit” synergistic photothermal‐immunotherapy based on a multifunctional carbon dot‐doped polymeric hydrogel with loaded oxaliplatin. Under laser irradiation, the hydrogel generates an initial photothermal ablation (“first‐hit”) while triggering OXA release. The released OXA induces potent immunogenic cell death and thereby activates long‐standing antitumor immune response (“second‐ICD, Therapy, carbon dots, hydrogel, photothermalhit”). This “dual‐hit” therapeutic strategy is successfully performed in tumor‐bearing mice.
“Dual‐Hit” Photothermal and Immunogenicity Activation by Structurally Simple Carbon Dots‐Doped Hydrogel
Effective tumor treatment can only be achieved by combining short‐acting, localized therapy with long‐acting, systemic anti‐tumor immunogenicity. Herein, we report a “dual‐hit” synergistic photothermal‐immunotherapy based on a multifunctional carbon dot‐doped polymeric hydrogel with loaded oxaliplatin. Under laser irradiation, the hydrogel generates an initial photothermal ablation (“first‐hit”) while triggering OXA release. The released OXA induces potent immunogenic cell death and thereby activates long‐standing antitumor immune response (“second‐ICD, Therapy, carbon dots, hydrogel, photothermalhit”). This “dual‐hit” therapeutic strategy is successfully performed in tumor‐bearing mice.
- 6 August 2025
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 256 (Pt 1) , 115001
Orthogonal programmed tri-modal tumor treatment based on structurally simple nanomedicines
- 6 August 2025
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 256 (Pt 1) , 115001
Orthogonal programmed tri-modal tumor treatment based on structurally simple nanomedicines
- Open Access
- 6 March 2025
- Published by Elsevier in Chemical Engineering Journal
- Vol. 509
Nanomedicine with simple structure for programmable heat-shock protein inhibition and sensitized synergistic therapy
- 6 March 2025
- Published by Elsevier in Chemical Engineering Journal
- Vol. 509
Open AccessNanomedicine with simple structure for programmable heat-shock protein inhibition and sensitized synergistic therapy
- Open Access
- 23 September 2024
- Published by Wiley in Advanced Materials
- Vol. 36 (46) , e2409592
Confined Flash Printing and Synthesis of Stable Perovskite Nanofilms under Ambient Conditions
The fabrication of stable perovskite nanofilm patterns is important for the development of functional optical devices. However, current production approaches are limited by the requirement for strict inert gas protection and long processing times. Here, a confined flash printing synthesis method is presented to generate perovskite nanofilms under ambient conditions, combining precursor transfer, perovskite synthesis, crystallization, and polymer protection in a single step within milliseconds. A laser simultaneously prints and induces the flash synthesis, confined in a polymer nanofilm, under normal ambient conditions. Due to its simplicity and flexibility, the method enables the combination and screening of many different perovskite precursor materials on various substrates. Besides for the development of novel perovskite materials and devices, the nanofilms can be applied for biodetection. The unique H2O2‐responsive property of the ultrathin perovskite quantum dot film is applied for biomolecule detection based on oxidase‐catalyzed enzymatic reactions.
- 23 September 2024
- Published by Wiley in Advanced Materials
- Vol. 36 (46) , e2409592
Open AccessConfined Flash Printing and Synthesis of Stable Perovskite Nanofilms under Ambient Conditions
The fabrication of stable perovskite nanofilm patterns is important for the development of functional optical devices. However, current production approaches are limited by the requirement for strict inert gas protection and long processing times. Here, a confined flash printing synthesis method is presented to generate perovskite nanofilms under ambient conditions, combining precursor transfer, perovskite synthesis, crystallization, and polymer protection in a single step within milliseconds. A laser simultaneously prints and induces the flash synthesis, confined in a polymer nanofilm, under normal ambient conditions. Due to its simplicity and flexibility, the method enables the combination and screening of many different perovskite precursor materials on various substrates. Besides for the development of novel perovskite materials and devices, the nanofilms can be applied for biodetection. The unique H2O2‐responsive property of the ultrathin perovskite quantum dot film is applied for biomolecule detection based on oxidase‐catalyzed enzymatic reactions.
- Open Access
- 12 September 2024
- Published by Wiley in ChemBioChem
- Vol. 25 (21) , e202400458
Bio‐electrocatalytic Alkene Reduction Using Ene‐Reductases with Methyl Viologen as Electron Mediator
Asymmetric hydrogenation of alkene moieties is important for the synthesis of chiral molecules, but achieving high stereoselectivity remains a challenge. Biocatalysis using ene‐reductases (EReds) offers a viable solution. However, the need for NAD(P)H cofactors limits large‐scale applications. Here, we explored an electrochemical alternative for recycling flavin‐containing EReds using methyl viologen as a mediator. For this, we built a bio‐electrocatalytic setup with an H‐type glass reactor cell, proton exchange membrane, and carbon cloth electrode. Experimental results confirm the mediator's electrochemical reduction and enzymatic consumption. Optimization showed increased product concentration at longer reaction times with better reproducibility within 4–6 h. We tested two enzymes, Pentaerythritol Tetranitrate Reductase (PETNR) and the Thermostable Old Yellow Enzyme (TOYE), using different alkene substrates. TOYE showed higher productivity for the reduction of 2‐cyclohexen‐1‐one (1.20 mM h−1), 2‐methyl‐2‐cyclohexen‐1‐one (1.40 mM h−1) and 2‐methyl‐2‐pentanal (0.40 mM h−1), with enantiomeric excesses ranging from 11 % to 99 %. PETNR outperformed TOYE in terms of enantioselectivity for the reduction of 2‐methyl‐2‐pentanal (ee 59 % ± 7 % (S)). Notably, TOYE achieved promising results also in reducing ketoisophorone, a challenging substrate, with similar enantiomeric excess compared to published values using NADH.
- 12 September 2024
- Published by Wiley in ChemBioChem
- Vol. 25 (21) , e202400458
Open AccessBio‐electrocatalytic Alkene Reduction Using Ene‐Reductases with Methyl Viologen as Electron Mediator
Asymmetric hydrogenation of alkene moieties is important for the synthesis of chiral molecules, but achieving high stereoselectivity remains a challenge. Biocatalysis using ene‐reductases (EReds) offers a viable solution. However, the need for NAD(P)H cofactors limits large‐scale applications. Here, we explored an electrochemical alternative for recycling flavin‐containing EReds using methyl viologen as a mediator. For this, we built a bio‐electrocatalytic setup with an H‐type glass reactor cell, proton exchange membrane, and carbon cloth electrode. Experimental results confirm the mediator's electrochemical reduction and enzymatic consumption. Optimization showed increased product concentration at longer reaction times with better reproducibility within 4–6 h. We tested two enzymes, Pentaerythritol Tetranitrate Reductase (PETNR) and the Thermostable Old Yellow Enzyme (TOYE), using different alkene substrates. TOYE showed higher productivity for the reduction of 2‐cyclohexen‐1‐one (1.20 mM h−1), 2‐methyl‐2‐cyclohexen‐1‐one (1.40 mM h−1) and 2‐methyl‐2‐pentanal (0.40 mM h−1), with enantiomeric excesses ranging from 11 % to 99 %. PETNR outperformed TOYE in terms of enantioselectivity for the reduction of 2‐methyl‐2‐pentanal (ee 59 % ± 7 % (S)). Notably, TOYE achieved promising results also in reducing ketoisophorone, a challenging substrate, with similar enantiomeric excess compared to published values using NADH.
- Open Access
- 5 September 2024
- Published by Wiley in The Chemical Record
- Vol. 24 (10) , e202400100
Multichannel Lanthanide‐Doped Nanoprobes for Serodiagnosis and Therapy
In this account, we will highlight recent progress in the development of multichannel lanthanide‐doped (MC−Ln) nanoprobes for highly efficient serodiagnosis and therapy, with a particular focus on our own work. First, we first provide a classification of the types of MC−Ln nanoprobes based on the contained type and number of signals. The merits of different types of nanoprobes and the reason using lanthanides are elucidated. Then, we provide an overview of the current uses of MC−Ln nanoprobes in serodiagnosis and therapy, focusing on the strategic exploration to improve the diagnostic and therapeutic performance from different perspectives. Finally, we present a prospective outlook on the future development and potential issues of next‐generation MC−Ln nanoprobes. We hope that this timely account will update our understanding of MC−Ln and similar nanoprobes for bioapplications and provide helpful references for the state‐of‐the‐art tools for serodiagnosis and therapy.
- 5 September 2024
- Published by Wiley in The Chemical Record
- Vol. 24 (10) , e202400100
Open AccessMultichannel Lanthanide‐Doped Nanoprobes for Serodiagnosis and Therapy
In this account, we will highlight recent progress in the development of multichannel lanthanide‐doped (MC−Ln) nanoprobes for highly efficient serodiagnosis and therapy, with a particular focus on our own work. First, we first provide a classification of the types of MC−Ln nanoprobes based on the contained type and number of signals. The merits of different types of nanoprobes and the reason using lanthanides are elucidated. Then, we provide an overview of the current uses of MC−Ln nanoprobes in serodiagnosis and therapy, focusing on the strategic exploration to improve the diagnostic and therapeutic performance from different perspectives. Finally, we present a prospective outlook on the future development and potential issues of next‐generation MC−Ln nanoprobes. We hope that this timely account will update our understanding of MC−Ln and similar nanoprobes for bioapplications and provide helpful references for the state‐of‐the‐art tools for serodiagnosis and therapy.